BCMA CAR T approvals (ide-cel 2021; cilta-cel 2022) deliver near-98% response in trials but require specialized centers, creating logistical constraints on access. Across >9 million UC patients, ...
Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results